scispace - formally typeset
H

Haiping Mao

Researcher at Sun Yat-sen University

Publications -  111
Citations -  3031

Haiping Mao is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Peritoneal dialysis & Hazard ratio. The author has an hindex of 27, co-authored 97 publications receiving 2451 citations.

Papers
More filters
Journal ArticleDOI

A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy

TL;DR: Increased STAT3 activity mediates activation of renal interstitial fibroblasts and the progression of renal fibrosis, and inhibition of STAT3 signaling with S3I-201 may hold therapeutic potential for fibrotic kidney diseases.
Journal ArticleDOI

Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy

TL;DR: It is suggested that pharmacological HDAC inhibition may induce antifibrotic activity by inactivation of renal interstitial fibroblasts and inhibition of renal tubular cell death and STAT3 may mediate those actions of HDACs.
Journal ArticleDOI

Atg5-mediated autophagy deficiency in proximal tubules promotes cell cycle G2/M arrest and renal fibrosis.

TL;DR: Atg5-mediated autophagy in proximal epithelial cells is a critical host-defense mechanism that prevents renal fibrosis by blocking G2/M arrest, suggesting the regulation of cell cycle progression by ATG5 is Autophagy dependent.
Journal ArticleDOI

Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China

TL;DR: In the general adult population from southern China, 12.1% has either proteinuria, haematuria and/or reduced eGFR, indicating the presence of kidney damage, with an awareness of only 9.6%.
Journal ArticleDOI

Clinical outcome of hyperuricemia in IgA nephropathy: a retrospective cohort study and randomized controlled trial.

TL;DR: Hyperuricemia predicts the progression of IgAN independently of baseline estimated glomerular filtration rate, and allopurinol may improve the control of blood pressure.